|
BGB-43395 Clinical Trials
4 actively recruiting trials across 3 locations
Pipeline
Phase 1: 4
Top Sponsors
- BeiGene2
- BeOne Medicines2
Indications
- Cancer4
- Hormone Receptor Positive Breast Cancer3
- Advanced Solid Tumor3
- Breast Cancer3
- Metastatic Breast Cancer2
Newport Beach, California2 trials
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Hoag Memorial Presbyterian
Phase 1
Birmingham, Alabama1 trial
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
University of Alabama At Birmingham Hospital
Phase 1
Denver, Colorado1 trial
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Sarah Cannon Research Institute (Scri) At Health One
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.